Industry
Ventana and Bayer to Collaborate on Companion Diagnostic
Ventana Medical Systems has entered into a strategic collaboration agreement with Bayer Pharma to develop a molecular companion diagnostic test that will identify patients most likely to benefit from a Bayer antibody-drug conjugate. More...24 Jan 2012
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Thyroid Test
Anti-Thyroid EIA Test
Automated Clinical Chemistry Analyzer
Envoy 500+
In Other News
Ventana and Syndax to Develop Companion Diagnostic
Quest Increases Presence in New Mexico with S.E.D. Labs Acquisition
MDx and M&A Markets Experience Lull in Late 2011
Hemoglobin A1c Test to Be Provided in Retail Pharmacies
Affymetrix Will Acquire eBioscience for USD 330 Million
Biohit Oyj Sells Liquid Handling Business to Sartorius
Ventana and ACD Promote In Situ RNA Hybridization Assay
Gentronix and BioQuanta to Distribute Mitoxis-Functional Metabolic Platform.
Clarient and Acorn Collaborate on Tumor Molecular Testing
Abbott Expands Agreement with GlaxoSmithKline to Develop Companion Diagnostic
IVD Market Expected to Grow Substantially in 2012-2014
Roche Acquires Verum Diagnostica, Leader in Platelet Function Testing
Export Driven Multidisciplinary Approach Wins EFF Manufacturing Award for 2011
Roche Diagnostics Establishes Alliance with Cedars-Sinai Medical Center
Zeiss Light and Electron Microscopy Combined in New Business Group
Leica Microsystems Acquires Labindia’s Microscopy and Histopathology Divisions
PerkinElmer Completes Acquisition of Caliper Life Sciences
Developing World Could Be the New IVD Growth Region
Spanish Company Develops Diagnostic Kit for Metastasis
Verinata, Illumina Sign Supply Agreement for Prenatal Diagnostics
Illumina and UNTHSC Apply New Sequencing Technologies to Forensics
Roche and Diagnostica Stago Discontinue Partnership
Sony to Accelerate POC Diagnostic Product Development Through Micronics Acquisition
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.